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Confirmatory factor analyses and theories of posttraumatic stress disorder (PTSD) support the 
clinical and scientific relevance of a distinct emotional numbing construct in PTSD.  Increased 
emotional numbing has been linked with increased nicotine use.  D eficits in reward system 
functioning may be related to symptoms of emotional numbing and nicotine use.  Previous 
research has found altered neurotransmitter function and brain activation in response to reward in 
reward system brain structures in PTSD.  In normal REM sleep, these brain structures have 
increased activity and are related to sleep-wake mechanisms, which may be dysregulated in 
PTSD. This study used polysomnography (PSG) and [18F]-FDG PET imaging to conduct region 
of interest analyses (ROIs) examining possible resting state brain activity deficits in Operation 
Enduring Freedom and Operation Iraqi Freedom veterans in the striatum and amygdala.  It was 
hypothesized that 1) increased emotional numbing would be associated with decreased activity 
during wakefulness and REM; 2) increased emotional numbing would be associated with 
increased nicotine use; and 3) increased nicotine use would be associated with decreased activity 
during wakefulness and REM.  Results indicate that increased emotional numbing corresponds 
with decreased activity during wakefulness in the striatum and amygdala, but not after adjusting 
for all non-emotional numbing symptoms of PTSD.  This pattern was reversed during REM, with 
increased emotional numbing corresponding with increased activity in the striatum, which 
survived adjusting for non-emotional numbing symptoms of PTSD.  Emotional numbing was not 
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correlated with nicotine use, possibly because heavy smokers were underrepresented in the 
sample.  Increased nicotine use was associated with decreased activity during wakefulness in the 
striatum, but was not related to activity during REM.  Results support the involvement of reward 
structures in nicotine use, emotional numbing, and other symptoms of PTSD.  Dysregulation in 
the reward system may exaggerate patterns of activity seen in healthy adults, with less activity in 
reward structures during quiet wakefulness and increased activity during REM sleep.             
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1.0  INTRODUCTION 
Posttraumatic Stress Disorder (PTSD) is a serious psychological disorder currently defined by 
the persistence of three clusters of seventeen total symptoms for at least one month following a 
traumatic experience, which causes significant distress or impairment in functioning.  T he re-
experiencing cluster (criteria B1-B5) contains symptoms such as intrusive recollections of the 
traumatic event, reactivity to trauma-related cues, and nightmares of the traumatic event.  The 
avoidance and numbing cluster (criteria C1-C7) includes items such as avoidance of trauma-
related cues, restricted affect, and diminished interest in activities.  F inally, the hyperarousal 
cluster (criteria D1-D5) contains such symptoms as insomnia, hypervigilance, and exaggerated 
startle response (American Psychiatric Association, 2000).  (See Table 1 for a complete listing of 
all seventeen symptoms).  Trauma associated with combat exposure and service in the military is 
a significant risk factor for PTSD.  More than 1.7 million men and women have served in the 
Unites States military in support of Operation Enduring Freedom in Afghanistan (OEF) and 
Operation Iraqi Freedom (OIF) since 2001(Sollinger, Fisher & Metscher, 2008), and estimates of 
overall PTSD prevalence among OEF/OIF veterans range from 10 to 15 percent (Ramchand et 
al., 2011).  T here is thus a particular impetus to understand the psychological factors and 
biological mechanisms which contribute to PTSD in OEF/OIF veterans.         
Although the current diagnostic criteria for PTSD presents a three factor model of PTSD 
symptoms, previous research on the factor structure of PTSD has supported a four factor model 
that divides the symptoms of PTSD into re-experiencing, avoidance, hyperarousal and emotional 
numbing (King et al., 1998; Asmundson, Stapleton, & Taylor, 2004).  This model separates the 
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single DSM-IV-TR avoidance and numbing symptom cluster into separate avoidance and 
emotional numbing clusters, with the empirically-based emotional numbing construct consisting 
of amnesia for the traumatic event, diminished interest in activities, detachment from others, 
restricted affect, and a sense of foreshortened future.  T he DSM-IV-TR offers a narrower 
theoretical definition of emotional numbing which includes only diminished interest, 
detachment, and restricted affect (American Psychiatric Association, 2000).  
According to Litz and Gray’s (2002) theory of emotional numbing, the symptoms of 
emotional numbing do not  reflect a complete inability of PTSD patients to experience positive 
emotions.  R ather, PTSD patients retain their complete pre-traumatic emotional capacity, but 
positive emotional responses become harder to access due to the salience of post-traumatic 
negative emotional responses, particularly in the presence of trauma-related cues and re-
experiencing symptoms.  T his suggests that symptoms of PTSD may be phasic, with re-
experiencing symptoms triggering periods of heightened emotional numbing, while hyperarousal 
symptoms further deplete emotional and cognitive resources necessary for positive emotions by 
redirecting attention to threat and anxiety cues.  Stein and Paulus (2009) characterized the 
distinction between emotional numbing and the other three clusters of re-experiencing, 
avoidance and hyperarousal as a dysregulation in the homeostatic balance between the approach 
and avoidance systems.  Emotional numbing is conceptualized as the result of dysfunction in 
reward processes leading to a downregulation of approach, while the remaining symptom 
clusters are conceptualized as the products of dysfunction in fear-related processes leading to an 
upregulation of avoidance.  T ogether, these theories provide a context for the importance of 
emotional numbing in PTSD and its relation to the other symptom clusters.         
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Emotional numbing is thus an important construct in PTSD symptomology, and is also 
present in other disorders, such as depersonalization disorder (Sierra et al, 2005). Emotional 
numbing is a predictor of chronic PTSD (Feeny et al., 2000) and is positively correlated with 
higher levels of alcohol misuse (Jakupcak et al., 2012), nicotine use (Kirby et al., 2008; Cook et 
al., 2009; Greenberg et al., 2012), sexual dysfunction (Nunnink et al., 2010), non-adherence to 
psychotherapy (Angeli, 2009), violent behaviors (Maguen et al., 2009), and poorer interpersonal 
relationships (Beck et al., 2009).  Empirical evidence also supports the existence of an emotional 
numbing construct in PTSD separate from depression (Feeny et al., 2000). Furthermore, 
emotional numbing has been identified as a significant factor of PTSD in western and non-
western cultures and in civilian and military samples, indicating a b road significance and 
applicability beyond American military service members (Costa et al., 2011). 
Despite the clinical relevance of emotional numbing, there is limited data on its 
neurobiological underpinnings.  Previous research on the neural correlates of PTSD suggests that 
underactivation in the medial prefrontal cortex (mPFC) may lead to overactivation in the 
amygdala due to less inhibition via downward projections from the mPFC to the amygdala 
(Koenigs & Grafman, 2009).  The amygdala is a critical structure in regulating fear responses, 
and dysregulation of the amygdala may explain chronic fear-related symptoms in PTSD.  
However, this model may not fully account for symptoms of emotional numbing, particularly 
anhedonia (Garfinkel & Liberzon, 2009).  Recent research has examined the role of the reward 
system in PTSD, since dysregulation in this system may explain symptoms of emotional 
numbing.  T wo previous fMRI studies have found lower levels of activation in response to 
reward in the reward system of PTSD patients relative to controls.  Sailer et al. (2008) found less 
activation in the nucleus accumbens, thalamus, and mesial PFC of 13 women with PTSD due to 
  
 4 
various traumas, as compared to healthy controls.  Elman et al. (2009) found less activation in 
the striatum, defined as the nucleus accumbens, caudate nucleus, and putamen, in 20 c ivilian 
men and women with PTSD due to various traumas, as compared to healthy controls.  Elman et 
al. (2009) additionally found that less activation in the striatum in response to reward was 
correlated with increases in two symptoms of emotional numbing, namely diminished interest 
and detachment. However, striatal activation was not correlated with restricted affect or sense of 
foreshortened future.  P TSD patients also demonstrated a non-significant trend towards less 
striatal deactivation in response to monetary loss, as compared to controls.  
Further support for the potential importance of the reward system in PTSD comes from 
Liberzon et al. (2007), who examined µ-opioid receptor binding potential (BP2) in healthy 
controls, combat-exposed controls, and combat-exposed PTSD patients using positron emission 
tomography (PET) and the radioactive opioid [11C] carfentanil tracer.  They found that both 
combat-exposed groups had lower BP2 than healthy controls in the nucleus accumbens and 
extended amygdala, as well as the dorsal frontal and insular cortex.  Reduced BP2 was found in 
the anterior cingulate cortex of PTSD patients relative to both non-PTSD groups, and in the 
amygdala of combat-exposed controls relative to PTSD patients and healthy controls.  P TSD 
patients had a higher BP2 in the orbitofrontal cortex than healthy controls.  C ombat-exposed 
controls had a higher BP2 in the orbitofrontal cortex and lower BP2 in the amygdala than both 
PTSD patients and healthy controls.  T hese regions are involved in reward and emotional 
processes, and abnormal opioid receptor functioning in these areas may contribute to emotional 
numbing and anhedonia.   
Consistent with the finding of altered opioid receptor functioning in PTSD, animal 
research has shown that inescapable stress produces increased opioid release in the presence of 
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trauma-related cues causing conditioned analgesia (Hyson et al., 1982). Foa, Zinbarg, and 
Rothbaum (1992) argued that this phenomenon approximates emotional numbing in humans 
with PTSD, and that analgesia in PTSD patients may be one manifestation of emotional 
numbing. Evidence of conditioned analgesia in PTSD patients supports this hypothesis (Pitman 
et al, 1990; Diener et al., 2012).     
Complementary to the finding of opioid-mediated analgesia in PTSD, it has also been 
hypothesized that a depletion of catecholamines, particularly norepinephrine and dopamine, may 
account for emotional numbing (van der Kolk et al., 1985).  Dopamine within the reward system 
is associated with positive emotions and feelings of pleasure, and opioid release triggers 
catecholamine release, causing an initial increase in dopamine followed by a period of depletion.  
These theories postulate that there may be alternating periods of increased and 
subsequently decreased opioid and catecholamine activity which relate to symptoms of 
emotional numbing.  The mixed evidence from preliminary evaluations of opiate antagonists and 
dopamine agonists provides some highly circumstantial evidence that either may potentially 
alleviate some symptoms of PTSD under the correct conditions.  A  preliminary study of the 
opiate antagonist nalmefene found a decrease in PTSD symptoms, including emotional numbing, 
in a small, uncontrolled sample of veterans (Glover, 1993).  The opiate antagonist naltrexone 
was found effective in reducing flashbacks in two case studies of an adult male and female (Bills 
& Kreisler, 1993).  However, there is no convincing support for the effects of nalmefene, and a 
preliminary study of naltrexone did not find clinically significant decreases in any PTSD 
symptoms (Lubin et al. 2002). Furthermore, opiate antagonists may actually increase symptoms 
of PTSD after initial administration (Glover, 1995). These mixed findings may indicate 
fluctuating levels of natural opioid release in the reward system, so that opioid antagonists 
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reduce symptoms during periods of increased opioid release (such as in the presence of a trauma-
related cue), but not otherwise.  There is also preliminary support for the hypothesis that PTSD 
may include at least periodic catecholamine depletion.  In three case studies of PTSD treatment 
with psychostimulants, Houlihan (2011) saw improvement in overall functioning and PTSD 
symptoms in three military veterans.  O ne veteran specifically reported improvements in 
symptoms of emotional numbing, consistent with the hypothesis that emotional numbing may be 
caused by catecholamine depletion.  H owever, these results have yet to be replicated and 
subjected to vigorous, controlled evaluation.       
In addition to psychostimulants, substances of abuse are also known to alter functioning 
in the reward system by triggering the release of mesolimbic dopamine (Blum et al., 2000), and 
21.7% of military veterans with PTSD have been found to have a comorbid substance abuse 
disorder (Petrakis, Rosenheck, & Desai, 2011).  Likewise, alcohol and nicotine use affect 
mesolimbic dopamine reward system function and are prevalent in civilians and military 
personnel with PTSD (Blum et al., 2000).  Furthermore, Jakupkap et al. (2010) found that 
emotional numbing symptoms were more strongly associated with alcohol misuse than other 
symptom clusters in OEF/OIF veterans, and that this relationship persisted after controlling for 
depression.  However, Maguen et al. (2009) found that only re-experiencing symptoms of PTSD 
predicted post-deployment problem drinking in veterans of the peacekeeping assignment in 
Kosovo.  
Three studies have linked nicotine use and symptoms of emotional numbing.  Kirby et al. 
(2008) found that among male OEF/OIF veterans with PTSD, current smokers had significantly 
higher symptoms of emotional numbing, but were statistically equal with non-smokers in all 
other symptom clusters.  Cook et al. (2009) found that veterans (with and without a diagnosis of 
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PTSD) with higher levels of overall PTSD severity were more likely to report heavy smoking 
(greater than or equal to 20 cigarettes per day), as were veterans with higher levels of emotional 
numbing.  None of the other symptom clusters of PTSD predicted smoking.  Greenberg et al. 
(2012) found that emotional numbing was the only symptom cluster to significantly predict 
lifetime smoking in U.S. adults with a trauma history after controlling for all other symptom 
clusters and demographic variables.  However, no clusters were uniquely associated with lifetime 
cigarettes per day, defined as the highest number of cigarettes smoked on a “usual” day.  The use 
of substances of abuse, alcohol and nicotine in veterans with PTSD may reflect an attempt to 
stimulate an underactive reward system (Blum et al., 2000), and the same underactivity may also 
contribute to emotional numbing.         
The preceding evidence suggests that there may be associations between emotional 
numbing, nicotine use, and reward system activity during wakefulness in PTSD.  In addition, 
there is also reason to suspect that neurobiological functioning in sleep influences symptoms of 
PTSD, including emotional numbing.  S leep disturbances, i.e. insomnia and nightmares, are 
among the most commonly reported symptoms of PTSD (Green, 2003), indicating that the 
neurobiological mechanisms responsible for PTSD can also alter sleep-wake brain mechanisms.  
Sleep deprivation has been shown to increase reactivity to both positive and negative stimuli in 
healthy adults, and can increase feelings of anxiety and negatively affect mood (Talbot et al., 
2010).  Using fMRI techniques, Gujar et al. (2011) observed increased activation in response to 
reward following sleep deprivation in the ventral tegmental area, left putamen, amygdala, and 
left insular cortex, while Venkatraman et al. (2007; 2011) observed increased activation in the 
right nucleus accumbens and ventral striatum, and decreased activation in the insular and 
orbitofrontal cortices, indicating a greater response to reward and a lesser response to loss.  Sleep 
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regulation and reward processing in the mesolimbic pathway are jointly influenced by orexin 
projections from the lateral hypothalamus, which may mediate the relationship between sleep 
and reward (Harris, Wimmer, and Aston-Jones, 2005; Sakurai, 2007). This indicates that 
mesolimbic activity during sleep may be of relevance to the neurobiological model of PTSD, 
particularly during rapid eye movement sleep (REM).   
In healthy REM sleep, there is a r elative increase in glucose metabolism compared to 
quiet wakefulness in brain structures relevant to reward processing and PTSD, including the 
amygdala, ventral striatum, and orbitofrontal and cingulate cortices (Nofzinger et al., 1998).  
Dysregulation in REM sleep thus has the potential to affect reward processing and symptoms of 
PTSD, including emotional numbing, and may contribute to nicotine use.       
This study used [18F]-fluorodeoxyglucose (FDG) PET in conjunction with 
polysomnography (PSG) in order to investigate the neural correlates of emotional numbing, 
nicotine use, and relative regional cerebral metabolic rate of glucose (rCMRglc) in both quiet 
wakefulness and REM among OEF/OIF veterans, with a primary focus on brain regions of the 
reward system.  Due to previous findings of less activation in the reward system in response to 
reward in adult PTSD patients (Sailer et al., 2008; Elman et al., 2009), in addition to the 
dysregulation of neurotransmitters implicated in reward and emotional processing, it was firstly 
hypothesized that there would be a negative correlation between emotional numbing and relative 
rCMRglc in wakefulness and REM in reward structures.  B ased on the previous findings of 
increased nicotine use with increased emotional numbing (Kirby et al., 2008; Cook et al. 2009; 
Greenberg et al., 2012), it was secondly hypothesized that nicotine use and severity of emotional 
numbing symptoms would be positively correlated.  It was thirdly hypothesized that there would 
be a negative correlation between nicotine use and relative rCMRglc in wakefulness and REM in 
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rewards structures, as nicotine use may represent an attempt to stimulate a dysregulated reward 
system.   
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2.0  METHODS 
2.1 PARTICIPANTS 
Data were collected from participants enrolled in one of two study protocols (Grant PT073961-
W81XWH-07-PTSD-IIRA and Grant MH083035) conducted by the Veterans Sleep Studies in 
the Department of Psychiatry at the University of Pittsburgh between June 2008 a nd October 
2011.  Procedures for both protocols were approved by the University of Pittsburgh, Institutional 
Review Board and the Human Use Subcommittee of the Radioactive Drug Safety Committee.  
Written informed consent was obtained from participants before being enrolled in the study and 
compensation was provided.  E ligible participants were 18-50 year old male and female 
OEF/OIF veterans recruited through local media advertising and military-focused health fairs.  
Participants were excluded for a diagnosis of current, untreated severe depression, history of 
substance or alcohol abuse or dependence within three months prior to study enrollment, 
significant or unstable acute or chronic medical conditions, history of traumatic brain injury or 
current concussive symptoms, current sleep disorders other than insomnia or nightmares, a 
traumatic experience within three months prior to study enrollment, presence of implanted 
devices or metal in the body, fear of enclosed spaces, previous radiation exposure within the past 
year exceeding recommended safety limits, pregnancy or breastfeeding, and unexpected, 
untreated, or serious EKG findings.  In addition, participants had not taken medications known to 
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affect sleep or wake function within a minimum of two weeks prior to beginning study 
procedures.  Sobriety was required during all study procedures.  Participants were requested not 
to consume more than four cups of coffee or the caffeine-equivalent per 24 hour period, and no 
more than two alcoholic drinks per day, or more than 14 d rinks per week on average.  
Participants were permitted to remain in ongoing counseling services they may have been 
receiving prior to study enrollment, but were excluded if they were receiving cognitive 
behavioral therapy for PTSD.                                             
2.2 ASSESSMENTS 
Psychiatric symptoms were assessed by a research clinician during a diagnostic interview using 
the following standardized assessments: 
Structured Clinical Interview for DSM-IV (SCID) – The SCID assesses current and past 
symptoms of DSM-IV disorders, including mood, anxiety, psychotic, alcohol, substance, 
somatic, and eating disorders (First et al., 1996). 
Structured Interview for DSM-IV Sleep Disorders (SID-SD) – The SID-SD assesses the presence, 
frequency, and severity of current and past symptoms of DSM-IV sleep disorders, as well as 
other common sleep disorders including obstructive sleep apnea and restless leg syndrome.  
Clinician Administered PTSD Scale-Part 1 (CAPS) – The CAPS assess the frequency and 
intensity of the 17 DSM-IV diagnostic criteria for PTSD (Weathers, Keane, & Davidson, 2001).  
This study utilized the CAPS to assess past month and lifetime PTSD symptoms.  A minimum 
score of one for frequency and two for intensity was required of an item to contribute to a 
diagnosis of PTSD.  Per the emotional numbing factor of King et al. (1998), an emotional 
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numbing scale was created by summing the frequency and intensity scores of items 8-12 (C3-
C7), yielding a possible emotional numbing score 0-40 with higher scores indicating greater 
endorsement of emotional numbing symptoms.  A non-emotional numbing scale was created by 
summing the frequency and intensity scores of the remaining items (1-7, 13-17), yielding a 
possible non-emotional numbing score 0-96, which was used as a covariate to control for PTSD 
severity among all symptoms other than emotional numbing. The emotional numbing and non-
emotional numbing scales are summarized in Table 1. 
Pittsburgh Sleep Quality Index (PSQI) – The PSQI is a s elf-report measure of past month 
subjective sleep quality with higher scores indicating lower quality sleep.  S cores less than 5 
indicate good quality sleep (Buysse et al., 1989). 
Beck Depression Inventory (BDI) – The BDI is a s elf-report questionnaire that assesses the 
severity of depression symptoms, with scores of 13 and below indicating minimal depression 
(Beck, Steer, & Brown, 1996).   
  
 13 
Table 1. PTSD symptoms included on emotional numbing and non-emotional numbing scales 
 
Combat exposure was measured with the Combat Exposure Scale (CES), which is a 
seven item self-report questionnaire that assesses the frequency of dangerous combat 
experiences.  S cores range from 0-41, with higher scores indicating a higher frequency of 
dangerous combat experiences (Keane et al., 1989).     
Sleep and substance use behaviors were assessed for one to two weeks following the 
diagnostic interview, using the Pittsburgh Sleep Diary (PghSD) (Monk et al., 1994).  Participants 
recorded their behavior in the PghSD twice per day.  In the morning, participants reported on 
their previous nights’ sleep, including sleep quantity and quality measures.  Habitual bedtimes 
and rising times were calculated from this sleep diary data.  In the evening, participants reported 
on their sleep-related activities during the day, including their caffeine intake, nicotine and 
alcohol use, and other medication use.  Average daily use of caffeine, nicotine and alcohol was 
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computed from PghSD reports.  Although participants were supposed to complete the PghSD for 
7-14 days, the prospective, self-report nature of the PghSD makes it difficult to ensure that 
participants complete it fully.  In the case that a diary was not fully completed, data was obtained 
and averaged according to the days that were completed.  In total, seven participants provided 
less than seven days of PghSD data.  Three of these participants provided six days of data, two 
provided five days of data, and two provided four days of data. No participants provided less 
than four days of PghSD data.  Participants additionally completed a urine drug screen and 
breathalyzer test before completing study procedures to verify sobriety.  S moking was not 
permitted during imaging procedures or between the participant’s habitual bedtime and morning 
awakening time while completing a sleep study, but was not otherwise restricted.   
In addition, a sleep screening study was completed in the University of Pittsburgh 
Neuroscience and Clinical Translational Research Center (NCTRC) (Grant UL1RR024153) to 
verify the absence of obstructive sleep apnea or any other exclusionary sleep disorders.  
Physical health was assessed by a study physician during a physical evaluation including 
a medical history questionnaire, a traumatic brain injury screening questionnaire, a blood draw to 
test blood chemistry, a urine drug screen, and an EKG. Included participants did not endorse any 
current concussive symptoms or other significant medical conditions.   
Additionally, magnetic resonance imaging (MRI) was used to assess any potential brain 
pathology and served for co-registration with PET images.  An MRI scan was completed at the 
University of Pittsburgh Magnetic Resonance Research Center (MRRC) using a Siemens 3T Trio 
scanner.  An axial series oriented to the anterior-posterior commissure line with a 5mm section 
thickness/1mm intersection gap was used to detect structural brain anomalies.  A  volumetric 
MPRAGE sequence was obtained in the sagittal plane, which was optimized for maximal 
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contrast between brain matters and used a high resolution slice thickness of 1.5/1.2mm, 0mm 
interslice.  T his image served for MR-guided region of interest (ROI) placement and co-
registration with PET images via Automated Image Restoration (AIR).  
2.3 POLYSOMNOGRAPHY AND PET PROCEDURES 
PSG and PET procedures were conducted according to validated methods (Nofzinger et al., 
1998).  P articipants stayed overnight in the NCTRC a minimum of four nights, including the 
sleep screening study. Figure 1 provides a graphic overview of the experimental protocol.  On 
each experimental night, participants were monitored via PSG, including bilateral central and 
occipital EEG channels, EOG, and submentalis EMG, and had intravenous tubing placed in each 
arm to allow for accommodation and administration of the [18F]-FDG and to sample blood 
radiation levels following injection.  Participants were instructed to go to bed each night at their 
habitual bedtime, as determined by PghSD data.  Participants completed two PET scans over the 
four nights in the lab.  The first scan assessed relative rCMRglc in wakefulness, while the second 
scan assessed relative rCMRglc in REM.   
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Figure 1. Timeline of PET procedures 
GNT = habitual bedtime; GMT = habitual awakening time. 
In order to optimize alertness during the wake scan, the first [18F]-FDG injection occurred 
two to four hours after the habitual wake time following Night 2.  Participants were instructed to 
lie supine with their eyes closed while still being monitored by PSG to ensure wakefulness.  
After a 15 minute accommodation period, participants were injected with the [18F]-FDG through 
the intravenous catheter already in place.  The uptake of [18F]-FDG is complete at 20 minutes, 
and is 70-80% maximal in the first 12 minutes (Nofzinger et al., 1998).  P articipants thus 
remained in a state of quiet wakefulness for an additional 20 m inutes following the injection.  
After the completion of the uptake period, participants were transported from the NCTRC to the 
PET center facilities, where scans were completed using a S iemens/CTI ECAT HR+ scanner 
with a N euro-insert (CTI PET Systems, Knoxville, TN) in 3D mode.  S ixty minutes after 
injection time, a series of six sequential five minute emission scans was begun, allowing for a 
composite 30 m inute scan which excluded data corrupted by movement.  T he emission scans 
were followed by a 15 minute transmission scan to allow for quantitative correction of 
attenuation.  
Wake Scan 
 
REM Scan 
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After completing the wake scan, participants completed a recovery night in the NCRTC 
without a PET scan.  On the fourth night, injection of [18F]-FDG was made at the onset of the 
second REM period, as indicated by PSG.  T he participant was awoken 20 m inutes after the 
injection and the same scanning procedures following the injection during wakefulness were 
repeated.  The participant was then allowed to return to the NCRTC and sleep ad lib through the 
morning.   
2.4 IMAGE ANALYSES 
PET scans were considered valid if participants remained in the target state for at least 10 
minutes after injection and did not move during the scan.  One to two non-contiguous epochs of 
a state which was not the target state were allowed within the first 10 minutes.  A lthough 
injection times were chosen to optimize state consistency, states can change quickly and sleep in 
veterans tends to be particularly fragmented.  H owever, uptake of [18F]-FDG is low after the 
initial 10 minute uptake period, so PET scans still approximate the stage maintained in the first 
10 minute period, regardless of state inconsistency in the second 10 minutes of uptake 
(Nofzinger et al., 1998).  Brain/non-brain segmentation was applied to the MR data to create a 
brain tissue mask for sampling the PET data for the purpose of whole brain normalization of 
regional metabolic rate of deoxyglucose (MRDglc).  A bsolute brain glucose metabolism was 
estimated based on s ix venous plasma samples collected every 8 m inutes starting 45 m inutes 
after [18F]-FDG injection.  This was used to correct for between subject variability.  The relative 
regional cerebral metabolic rate of glucose (rCMRglc) value served as the primary measure of 
neuronal activity level.  PET images were reconstructed using standard commercial software as 
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63 transaxial slices (center to center 2.4 mm) with approximate  6mm full-width, half-maximum 
resolution.  Automatic Image Restoration software was used to co-register PET and MR image 
sets.  MR and PET images were then translated in Montreal Neurological Institute (MNI) space 
according to standard equations to allow for between subject comparisons. 
2.5 STATISTICAL ANALYSES 
Demographic and clinical variables were summarized and compared using SPSS 19 software. 
Independent sample t-tests and chi-square tests were used to compare PTSD with non-PTSD 
patients, nicotine with non-nicotine users, and males with females within both samples.  
Correlations among continuous variables were computed using Pearson correlations.  Statistical 
Parametric Mapping version 8 (SPM8) (http://www.fil.ion.ucl.ac.uk/spm/software/spm8/) was 
used to conduct negative and positive correlational analyses between relative rCMRglc and 
emotional numbing and daily average nicotine use within the wake and REM samples.  The 
emotional numbing correlations were also repeated using non-emotional numbing as a covariate. 
Region of interest analyses (ROIs) were conducted for the striatum, defined as the bilateral 
caudate, putamen and nucleus accumbens. ROIs were also conducted for the bilateral amygdala.  
If a statistically significant cluster of contiguous voxels was found within these structures, ROIs 
were conducted for the individual structures within the larger ROI structure (e.g. right/left 
striatum, right/left caudate, right/left putamen, right/left nucleus accumbens, right/left amygdala) 
in order to further localize the cluster.  Given the a priori nature of the hypotheses under scrutiny, 
statistical significance of clusters within the ROIs was assessed using the uncorrected p value 
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(puncorr) of the maximum voxel of significance.  A maximum of puncorr=0.01 was used as a cut off 
for significance.   
Exploratory whole brain correlational analyses were also conducted. The results of these 
analyses are presented in Appendix A as supplementary material.  A  maximum cluster-level 
uncorrected p value of puncorr=0.05 was permitted in order to include a cluster in the results, but 
the more stringent cluster-level family-wise corrected p value (pfwe-corr) was also reported.  These 
clusters received alphabetic labels for ease of identification.   
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3.0  RESULTS 
3.1 SAMPLE CHARACTERISTICS 
Thirty six participants met inclusion criteria and completed at least one valid [18F]-FDG PET 
scan.  T wenty five participants completed valid wake and REM scans, nine participants only 
completed a valid wake scan, and two participants only completed a valid REM scan.  
Participants who completed a valid wake scan comprised the wake sample (n=34) and 
participants who completed a valid REM scan comprised the REM sample (n=27). 
3.1.1 Demographics 
3.1.1.1 Wake Sample 
Thirty four participants met inclusion criteria and completed a valid [18F]-FDG PET scan during 
wakefulness.  The demographic and clinical characteristics of this sample are summarized in 
Table 2. Participants were 22 to 45 years old and Caucasian males comprised the majority of the 
sample.  Combat exposure ranged from light to heavy combat, with an average combat exposure 
of light-moderate (Mean=15.47, SD=10.60).  A verage emotional numbing and non-emotional 
numbing were moderate for the PTSD sample (Mean=13.38, SD=6.10; and Mean=44.69, 
SD=11.03) and low for the non-PTSD sample (Mean=2.83, SD=3.97; and Mean=12.39, 
SD=8.13).  Emotional numbing scores ranged from 0-25 in the PTSD sample and 0-13 in the 
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non-PTSD sample.  The distribution of emotional numbing scores for each sample is displayed 
in Figure 2. There were non-significant trends for females to have higher emotional numbing and 
non-emotional numbing scores than males.  Within the entire wake sample, average symptoms of 
depression were mild, with a mean BDI score of 5.32 (SD= 4.98) well below the clinical cut off 
of 13.  Sleep difficulties were mild to moderate within the wake sample, with a mean PSQI score 
of 5.74 (SD=3.65) slightly above the clinical threshold score for good sleep.  PTSD patients had 
moderately poor sleep with a mean PSQI score of 8.13 ( SD=3.50) versus non-PTSD patients 
who had relatively good sleep with a mean PSQI score of 3.61 ( SD = 2.20). Average daily 
nicotine, alcohol and caffeine use were low within the entire wake sample.  A verage daily 
nicotine use for the nicotine user sample was moderate with a mean of 7.75 dos es per day 
(SD=5.23).  Because there were only five females and five non-Caucasians in the wake sample, 
gender and race differences could not be explored.   
Table 2. Wake sample demographic and clinical characteristics 
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Figure 2. Wake sample emotional numbing scores 
3.1.1.2 REM Sample 
Twenty seven participants met inclusion criteria and completed a valid [18F]-FDG PET scan 
during REM.  The demographic and clinical characteristics of this sample are summarized in 
Table 3. Participants were 22 to 40 years old and Caucasian males comprised the majority of the 
sample.  Combat exposure ranged from light to heavy combat, with an average combat exposure 
of light-moderate (Mean=15.56, SD=10.12).  Av erage emotional numbing and non-emotional 
numbing were moderate for the PTSD sample (Mean=13.33, SD=6.28; and Mean=42.87, 
SD=11.67) and low for the non-PTSD sample (Mean=3.42, SD=4.60; and Mean=13.83, 
SD=9.38).  Emotional numbing scores ranged from 0-25 in the PTSD sample and 0-13 in the 
non-PTSD sample.  The distribution of emotional numbing scores for each sample is displayed 
in Figure 3. There were non-significant trends for females to have higher emotional numbing and 
non-emotional numbing scores than males, and females were significantly more likely than 
males to receive a diagnosis of PTSD.  Within the entire REM sample, average symptoms of 
depression were mild, with a mean BDI score of 6.04 (SD= 5.06) well below the clinical cut off 
of 13.  Sleep difficulties were mild to moderate within the REM sample, with a mean PSQI score 
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of 6.37 (SD=3.75) slightly above the clinical threshold score for good sleep.  PTSD patients had 
moderately poor sleep with a mean PSQI score of 8.07 ( SD=3.63) versus non-PTSD patients 
who had relatively good sleep with a mean PSQI score of 4.25 ( SD = 2.77). Average daily 
nicotine, alcohol and caffeine use were low within the entire REM sample.  A verage daily 
nicotine use for the nicotine user sample was moderate with a mean of 9.85 doses per day 
(SD=8.76).  Because there were only five females and three non-Caucasians in the REM sample, 
gender and race differences could not be explored.   
Table 3. REM sample demographic and clinical characteristics 
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Figure 3. REM sample emotional numbing scores 
       
3.1.2 Correlations Among Variables 
Correlations among demographic and clinical variables are summarized in Table 4 for the wake 
sample and Table 5 for the REM sample.  There were significant, moderately strong, positive 
correlations among emotional numbing, non-emotional numbing, depressive symptoms and poor 
sleep quality in both samples. There was a significant, moderate, positive correlation between 
daily average nicotine and caffeine use in the wake sample.  This relationship also appeared as a 
non-significant trend in the REM sample (p=0.087).  D aily average nicotine and caffeine use 
were not significantly correlated with emotional numbing, non-emotional numbing, depressive 
symptoms, or sleep quality in either sample.  There was a significant, moderate, negative 
correlation between daily average alcohol use and non-emotional numbing in the REM sample.  
This relationship also appeared as a non-significant trend in the wake sample (p=0.064). There 
was also a n on-significant trend in both samples of a moderate, negative correlation between 
daily average alcohol use and emotional numbing (p=0.082 in wake, and p=0.058 in REM).     
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Table 4. Correlations among variables in wake sample 
 
Table 5. Correlations among variables in REM sample 
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3.2 REGION OF INTEREST ANALYSES    
Results of the ROI analyses are summarized in Table 6.  A ll of the reported clusters were 
significant at the maximum voxel of significance puncorr=0.01 level, but none of the clusters were 
significant at the cluster-level puncorr=0.05 or pfwe-corr=0.05 levels.      
Table 6. Summary of significant clusters in ROI analyses 
  
3.2.1 Negative Correlations 
During wakefulness, increased emotional numbing was associated with decreased relative 
rCMRglc in three clusters of continuous voxels located in the right striatum, left putamen, and 
left amygdala (Figure 4).  During REM, increased emotional numbing was only associated with 
EN = Emotional numbing without covariates; ENCovNonEN = Emotional numbing controlling for non-emotional numbing; NicAve = Daily average nicotine use; k 
= number of voxels included in cluster; Z = test of significance of the maximum voxel of significance within the cluster; x,y,z = MNI coordinates of the maximum 
voxel of significance 
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decreased relative rCMRglc in a s ingle cluster located in the right putamen (Figure 5).  A fter 
controlling for non-emotional numbing, however, increased emotional numbing was not 
associated with decreased relative rCMRglc during wakefulness or REM.   
During wakefulness, increased daily average nicotine use was associated with decreased 
relative rCMRglc in a single cluster of continuous voxels located in the left striatum (Figure 6).  
During REM, however, increased daily average nicotine use was not associated with decreased 
relative rCMRglc. 
 
 
Figure 4. Decreased relative rCMRglc in wake with increased emotional numbing without covariates 
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Figure 5. Decreased relative rCMRglc in REM with increased emotional numbing without covariates 
 
 
Figure 6. Decreased relative rCMRglc in wake with increased nicotine use 
3.2.2 Positive Correlations 
During wakefulness, increased emotional numbing was not associated with increased relative 
rCMRglc.  After controlling for non-emotional numbing, however, increased emotional numbing 
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was associated with increased relative rCMRglc during wakefulness in one cluster located in the 
right amygdala (Figure 7).  D uring REM, increased emotional numbing was associated with 
increased relative rCMRglc in two clusters of continuous voxels located in the bilateral caudate 
(Figure 8).  A fter controlling for non-emotional numbing, increased emotional numbing was 
associated with increased relative rCMRglc during REM in three clusters located in the right 
caudate and bilateral amygdala (Figure 9).   
During wakefulness, increased daily average nicotine use was associated with increased 
relative rCMRglc in three clusters located in the right putamen, left caudate, and right amygdala 
(Figure 10).  D uring REM, however, increased daily average nicotine use was not associated 
with increased relative rCMRglc.  
 
 
Figure 7. Increased relative rCMRglc in wake with increased emotional numbing controlling for non-emotional 
numbing 
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Figure 8. Increased relative rCMRglc in REM with increased emotional numbing without covariates 
 
 
Figure 9. Increased relative rCMRglc in REM with increased emotional numbing controlling for non-emotional 
numbing 
  
 31 
 
Figure 10. Increased relative rCMRglc in wake with increased nicotine use 
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4.0  DISCUSSION 
This study used [18F]-FDG PET imaging and PSG to examine the neural correlates of emotional 
numbing and daily average nicotine use during wakefulness and REM in OEF/OIF veterans.  
Consistent with the a priori hypotheses, ROI analyses revealed that decreased relative rCMRglc 
was associated with increased emotional numbing in the striatum, particularly during 
wakefulness in the right striatum and left putamen.  Lower baseline activity in these areas of the 
reward system during wakefulness may indicate a higher threshold for stimulating positive 
emotion and reward processes, consistent with the finding of less activation in response to 
reward in patients with PTSD (Sailer et al., 2008; Elman et al., 2009).  However, this relationship 
did not appear to be unique to emotional numbing, as controlling for non-emotional numbing 
removed the associations between decreased relative rCMRglc and increased emotional 
numbing.  Thus the striatum may also be relevant to symptoms of PTSD other than emotional 
numbing.  This study did not control for the other symptom clusters individually, however, so 
this study cannot provide definitive evidence regarding which other symptoms of PTSD may 
also be negatively associated with relative rCMRglc in the striatum.  Previous research has 
shown this area may be involved in sleep-wake regulation, and thus potentially also related to the 
sleep disturbances in PTSD.  S imilarly, symptoms of hyperarousal and re-experiencing are 
thought to be closely associated with both emotional numbing and brain structures related to the 
reward system, which may include the striatum.     
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Contrary to expectations, ROI analyses also revealed that increased relative rCMRglc in 
the striatum was associated with increased emotional numbing during REM, specifically in the 
bilateral caudate.  Relative rCMRglc in a small cluster in the right putamen was negatively 
associated with emotional numbing, but this relationship was much smaller than the positive 
association and did not survive controlling for non-emotional numbing.  The positive 
relationship appeared to be unique to emotional numbing in the right caudate, as it survived 
controlling for non-emotional numbing, although as a smaller cluster of continuous voxels. This 
may be consistent with phasic theories of PTSD symptomology if trauma survivors are 
potentially more vulnerable to trauma-related cues and re-experiencing symptoms in REM, 
leading to subsequent daytime emotional numbing.  Exposure to trauma-related cues may come 
from nightmares present in REM, which cannot be actively avoided except by avoiding sleep 
entirely or awakening at the onset of a nightmare.  The natural increase in reward system activity 
during REM may also trigger a reversal of dysregulation within the reward system, so that 
activity is more underactivated in wakefulness and more overactivated in REM as emotional 
numbing and overall PTSD symptoms increase.       
Contrary to expectations and previous findings (Kirby et al., 2008; Cook et al., 2009; 
Greenberg et al., 2012), emotional numbing was not associated with nicotine use in the present 
sample, which may be due to the relatively low nicotine use among nicotine users.  Only two 
participants consumed the nicotine equivalent of 20 or more cigarettes per day, which was the 
cut off for the category of heavy smokers previously associated with emotional numbing severity 
(Cook et al., 2009).  The results of the nicotine use analyses should thus be treated with some 
caution, as they may not be representative of the heaviest smokers.  Nonetheless, ROI analyses 
revealed that decreased relative rCMRglc in wakefulness was associated with increased daily 
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average nicotine use in the striatum, specifically the left striatum, which was consistent with the 
hypothesis that patients may try to stimulate an underactive reward system.  This also paralleled 
the finding of a cluster in the left putamen with a negative association between rCMRglc and 
emotional numbing without covariates, suggesting that underactivity in the left striatum may be 
involved in both (non-specific) emotional numbing and nicotine use.  However, this negative 
relationship was not present in REM as expected, nor was nicotine use positively associated with 
rCMRglc in the striatum as was emotional numbing.  Furthermore, clusters of increased relative 
rCMRglc in the striatum, specifically the right putamen and left caudate, and in the right 
amygdala were also associated with increased daily average nicotine use during wakefulness.  
However, these clusters were much smaller than the cluster found in the negative correlation, and 
were on t he threshold for significance.  T here is thus more evidence to support a negative 
correlation between daily average nicotine use and relative rCMRglc in the striatum than a 
positive correlation.  This evidence tentatively suggests that there may be a relationship between 
the striatum and nicotine use and emotional numbing, but these results should be treated with 
caution given the potentially skewed sample of nicotine users and lack of direct correlation 
between emotional numbing and nicotine use, as well as the lack of parallel findings in REM. 
Finally, ROI analyses revealed relatively small but significant clusters within the 
amygdala that were generally consistent with striatal activity, indicating that the amygdala, 
which regulates the salience of emotions, may also be related to emotional numbing.  I n 
wakefulness, relative rCMRglc in the left amygdala was negatively associated with emotional 
numbing without covariates, as was the left putamen.  In contrast, relative rCMRglc in the right 
amygdala in wakefulness and the bilateral amygdala in REM was positively associated with 
emotional numbing after controlling for non-emotional numbing.  This finding provides evidence 
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that the amygdala may be involved in emotional numbing beyond its established role in fear- and 
anxiety-related symptoms in PTSD.       
Results thus indicate that the striatum is an important structure in PTSD pathology, both 
for emotional numbing and other symptoms of PTSD, and that patterns of underactivity in 
wakefulness may be reversed as patterns of overactivity in REM as symptoms of emotional 
numbing increase.  A lthough daily average nicotine use was not associated with emotional 
numbing, it was associated with decreased relative rCMRglc in the striatum, which is consistent 
the hypothesis that nicotine users may be trying to stimulate positive experiences in an 
underactive reward system.  Finally, these results indicate that the amygdala, which is associated 
with the salience of emotional experiences, may play a role in emotional numbing as well as 
fear- and anxiety-related symptoms in PTSD.       
One limitation in the literature on e motional numbing is the heterogeneity in the 
definitions of emotional numbing that have been used across studies, and the difficulty that this 
presents for comparing the current results to previous studies.  This heterogeneity can be seen, 
for instance, in the literature on emotional numbing and nicotine use.  On the basis of King et 
al.’s (1998) four-factor model of PTSD, Cook et al. (2009) and Kirby et al. (2008) used the same 
five symptoms as the current study to define emotional numbing, although Cook et al. (2009) 
obtained their data from the PTSD Checklist-Military Version and Kirby et al. (2008) obtained 
their data from the Davidson Trauma Scale.  G reenberg et al. (2012) performed their own 
confirmatory factor analyses on data obtained from the Alcohol Use Disorder and Associated 
Disabilities Interview Schedule-IV, and produced a four-symptom factor for emotional numbing 
with excluded the amnesia item (which was placed instead with the avoidance symptoms).  Other 
studies examining emotional numbing have used only diminished interest, detachment, and 
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restricted affect, and either excluded the amnesia and foreshortened future items entirely (e.g. 
Maguen et al., 2009) or included them in other symptom clusters (e.g. Nunnink et al. (2010), 
who included amnesia and a sense of foreshortened future in the avoidance cluster).  This study 
chose to define emotional numbing based on the empirical evidence of King et al.’s (1998) four 
factor model of PTSD, which is also most consistent with the proposed revisions for the creation 
of a fourth factor of PTSD symptoms in the DSM 5 (www.dsm5.org).  The creation of a fourth 
sypmtom cluster which closely resembles King et al.’s (1998) emotional numbing cluster will 
hopefully spur research on the validity of this new symptom cluster, providing a basis for more 
homogenous definition of emotional numbing in future research, and enabling more valid 
comparisons across studies of emotional numbing in PTSD.  One disadvantage of an emotional 
numbing definition based on confirmatory factor analysis of PTSD measures, however, is that it 
may reduce the applicability of the construct to other disorders with are thought to contain an 
element of emotional numbing, such as major depression and depersonalization disorder.   
Future research is needed to verify and expand the results of the current study.  T his 
study lacked sufficient power to examine potential gender and race differences, and although 
smoking was not restricted except during lab stays, heavy smokers were underrepresented, which 
may have skewed the findings related to nicotine use.  T his study chose to focus on m ilitary 
veterans due to the current demands for their care, but results should also be replicated in civilian 
samples.  The results do support the hypothesis that increased emotional numbing is associated 
with dysregulation within the reward system, but future research will need to further elucidate 
the nature of this dysregulation, particularly the finding that there may be overactivity in the 
reward system in REM. This may reflect phasic presentation of PTSD symptoms, and the 
relationships between emotional numbing, the reward system, and the other symptoms of PTSD 
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ought to be explored, including the potential role of nightmares during REM influencing 
subsequent daytime emotional numbing.  Research should also explore the possibility of other 
mechanisms contributing to a general dysregulation within the reward system that exaggerates 
the natural increases and decreases in reward system activity across the sleep-wake cycle.  This 
mechanism may also be related to the mechanisms that contribute to insomnia and other sleep-
related difficulties in PTSD.  The reward system is thus a promising area of focus for future 
neurobiological research on PTSD.                  
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Appendix A 
EXPLORATORY WHOLE BRAIN ANALYSES 
Supplementary findings from the exploratory whole brain correlational analyses are presented 
individually and summarized in Figure 28.  
A.1 RELATIVE RCMRGLC AND EMOTIONAL NUMBING 
A.1.1 Negative Correlation 
Wakefulness 
Decreased relative rCMRglc during wakefulness was associated with increased emotional 
numbing in one cluster (A) of 5119 continuous voxels (MNI coordinates of maximum voxel of 
significance: -32, 52, 4;  Z = 4.26, puncorr<0.000). Cluster A was significant without correction 
(puncorr= 0.004) but not when corrected (pfwe-corr=0.152) and is presented in Figure 11.  Cluster A 
was located in the left hemisphere and included regions of the frontal and temporal lobes, 
including the middle frontal gyrus; frontal inferior, superior and middle orbital gyri; frontal 
superior gyrus; frontal inferior triangularis; and the temporal inferior, superior and middle gyri. 
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Cluster A extended medially into the insula, putamen, hippocampus, pallidum, and amygdala.  
Cluster A also extended slightly into the parietal inferior gyrus, the occipital inferior and middle 
gyri, fusiform and the rolandic operculum.   
 
Figure 11. Maximum voxel of significance Cluster A 
After controlling for non-emotional numbing, decreased relative rCMRglc during 
wakefulness was associated with increased emotional numbing in one, smaller cluster (B) of 
3526 continuous voxels (MNI coordinates of maximum voxel of significance: -32, 52, 2;  Z = 
3.91, puncorr<0.000).  Cluster B was significant without correction (puncorr= 0.014) but not when 
corrected (pfwe-corr=0.423) and is presented in Figure 12.  S imilarly to Cluster A, Cluster B was 
predominantly in the left hemisphere.  Cluster B was located primarily in the left frontal cortex, 
including regions of the frontal superior medial gyrus; frontal middle and superior gyri; frontal 
inferior, middle, and superior orbital gyri; and the frontal inferior triangularis. Cluster B also 
extended slightly into the left insula and midline anterior cingulate cortex. 
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Figure 12. Maximum voxel of significance Cluster B 
REM 
Decreased relative rCMRglc during REM was associated with increased emotional numbing in 
one large cluster (C) of 18,578 c ontinuous voxels (MNI coordinates of maximum voxel of 
significance: 22, 38, -12; Z = 3.77; puncorr<0.000).  C luster C was significant after correction 
(pfwe-corr<0.000), and is presented in Figure 13.  O pposite Clusters A and B, Cluster C was 
predominately located in the right hemisphere.  Cluster C was centered in the right temporal 
lobe, including the right temporal middle, inferior, and superior gyri.  Cluster C also included a 
smaller section of the left temporal superior gyrus; and bilateral Heschl’s gyri and fusiform.  
Cluster C extended anteriorly to the right postcentral, supramarginal, angular and parietal inferior 
gyri; the right frontal inferior triangularis; right frontal inferior orbital gyrus; right frontal inferior 
operculum; right precentral gyrus; bilateral frontal middle and superior gyri; bilateral frontal 
superior medial gyri; bilateral frontal superior, middle and medial orbital gyri; bilateral rolandic 
operculum and left gyrus rectus.  Cluster C extended posteriorly to the right cuneus; bilateral 
precuneus  and lingual gyri;  bilateral occipital middle, superior, and inferior gyri; and bilateral 
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cerebellum.  Cluster C also extended to the right putamen; left caudate; and bilateral calcarine; 
insula; hippocampus; and parahippocampal gyri.              
 
Figure 13. Maximum voxel of significance Cluster C 
After controlling for non-emotional numbing, decreased relative rCMRglc during REM 
was associated with increased emotional numbing in one, smaller cluster (D) of 4727 continuous 
voxels (MNI coordinates of maximum voxel of significance: 26, 50, 14; Z = 3.27, puncorr=0.001). 
Cluster D was significant without correction (puncorr=0.007) but not when corrected (pfwe-
corr=0.218), and is presented in Figure 14.  S imilarly to Cluster C, Cluster D was predominantly 
located in the right hemisphere.  C luster D included right and midline regions of the frontal 
cortex, including the right frontal middle and superior gyri; right and midline frontal superior 
medial gyri; right frontal inferior triangularis; right frontal inferior, middle, and superior orbital 
gyri; midline frontal medial orbital gyri; and right precentral gyrus.  Cluster D extended 
posteriorly to the right postcentral gyrus and ventrally to the right rolandic operculum.  Cluster D 
also extended ventromedially to the right insula and putamen.    
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Figure 14. Maximum voxel of significance Cluster D 
A.1.2 Positive Correlation 
Wakefulness 
Increased relative rCMRglc during wakefulness was associated with increased emotional 
numbing in two separate clusters of continuous voxels, with 3874 voxels in Cluster E and 2092 
voxels in Cluster F (MNI coordinates of maximum voxel of significance: -8, -26, 76; Z = 3.70, 
puncorr<0.000; and 0, 28 , 10; Z = 3.97, puncorr<0.000, respectively). Clusters E and F were 
significant without correction (puncorr=0.011; and puncorr=0.050, respectively) but not when 
corrected (pfwe-corr=0.342; and pfwe-corr=0.853, respectively) and are presented in Figures 15 and 
16.  C luster E was centered on t he midline region of the central sulcus. Cluster E included 
bilateral regions of the postcentral and precentral gyri; paracentral lobule; and superior motor 
area.  Cluster E also extended laterally into the left hemisphere, including regions of the frontal 
middle and superior gyri; and parietal inferior gyrus. Cluster F was located primarily in the 
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bilateral anterior and middle cingulate cortices, and extended to the midline caudate, and the 
right frontal superior and frontal superior medial gyri.  
 
Figure 15. Maximum voxel of significance Cluster E 
 
Figure 16. Maximum voxel of significance Cluster F 
After controlling for non-emotional numbing, increased relative rCMRglc during 
wakefulness was associated with increased emotional numbing in two separate clusters (G and 
H) of continuous voxels, with 3454 and 2939 voxels respectively (MNI coordinates of maximum 
  
 44 
voxel of significance: -8, -26, 78; Z = 4.70, puncorr<0.000; 50, -82, 14, Z = 2.96, puncorr=0.002, 
respectively). Clusters G and H were significant without correction (puncorr=0.015; and 
puncorr=0.023, respectively) but not when corrected (pfwe-corr=0.442; and pfwe-corr=0.594, 
respectively), and are presented in Figures 17 and 18.  Similarly to Cluster E, Cluster G included 
regions of the left and midline postcentral gyrus; bilateral precentral gyri and paracentral lobule; 
midline frontal superior gyri; and right superior motor area; and extended slightly into the left 
parietal superior and inferior gyri and supramarginal gyri.  Cluster H was located primarily in the 
midline occipital lobe, for which there was no equivalent in the uncontrolled analysis.  Cluster H 
included regions of the bilateral calcarine sulci and lingual gyrus; midline occipital middle and 
inferior gyri with very slight extension into the occipital superior gyri; and midline fusiform and 
cuneus, with a slight extension to the temporal middle gyrus.  There was no equivalent to Cluster 
F found in the controlled analysis. 
 
Figure 17. Maximum voxel of significance Cluster G 
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Figure 18. Maximum voxel of significance Cluster H 
REM 
Increased relative rCMRglc during REM was associated with increased emotional numbing in 
one cluster (I) of 3231 continuous voxels (MNI coordinates of maximum voxel of significance: -
2, 24, 12; Z = 3.07, puncorr=0.001). Cluster I was significant without correction (puncorr=0.021) but 
not when corrected (pfwe-corr=0.534) and is presented in Figure 19. Similar to Cluster F in 
wakefulness, Cluster I was located primarily in the limbic system.  C luster I included midline 
regions of the anterior and middle cingulate cortices; caudate; and superior motor area.  It also 
extended slightly to the right thalamus.  
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Figure 19. Maximum voxel of significance Cluster I 
After controlling for non-emotional numbing, increased relative rCMRglc during REM 
was associated with increased emotional numbing in three separate clusters (J, K and L) of 
continuous voxels, with 2893, 2716, and 2375 voxels respectively (MNI coordinates of 
maximum voxel of significance: 10, -2, 34; Z = 3.16, puncorr=0.001; -14, -36,-10, Z = 3.77, 
puncorr=0.031; and 8, -32, 72, Z  = 3.03, puncorr=0.001, respectively). Clusters J, K and L were 
significant without correction (puncorr=0.027; puncorr=0.031; and puncorr=0.042, respectively) but 
not when corrected (pfwe-corr=0.631; pfwe-corr=0.685; and pfwe-corr=0.789, respectively), and are 
presented in Figures 20, 21 and 22.  Similar to Clusters F and I, Cluster J was located primarily 
in the midline limbic system and included regions of the midline anterior and middle cingulate 
cortices; midline superior motor area; and left caudate, parahippocampal gyrus, hippocampus, 
and amygdala; with slight extension to the bilateral olfactory bulbs and right thalamus.  Cluster 
K was located primarily in the left and midline anterior cerebellum and extended into the limbic 
system. Cluster K included regions of the left and midline anterior cerebellum; midline 
hippocampus and parahippocampal gyrus; and left fusiform and lingual gyrus.  S imilar to 
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Clusters E and G, Cluster L included regions of the left and midline precentral and postcentral 
gyri; midline paracentral lobule and precuneus; left parietal inferior and superior gyri; and left 
supramarginal gyrus.   
 
Figure 20. Maximum voxel of significance Cluster J 
 
Figure 21. Maximum voxel of significance Cluster K 
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Figure 22. Maximum voxel of significance Cluster L 
        
A.2 RELATIVE RCMRGLC AND NICOTINE USE 
A.2.1 Negative Correlation 
Wakefulness and REM 
Increased daily average nicotine use was not significantly associated with decreased relative 
rCMRglc during wakefulness or REM.   
A.2.2 Positive Correlation 
Wakefulness 
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Increased relative rCMRglc during wakefulness was associated with increased daily average 
nicotine in three separate clusters (M, N, and O) of continuous voxels, with 5221, 2189,  and 
2143 voxels respectively (MNI coordinates of maximum voxel of significance: 22, -62, 58; Z = 
3.25, puncorr=0.001; -12, -28,52, Z = 3.23, puncorr=0.001; and 22, 6, 36, Z = 3.05, puncorr=0.001, 
respectively). Clusters M, N, and O were significant without correction (puncorr=0.004; 
puncorr=0.045; and puncorr=0.047, respectively) but not when corrected (pfwe-corr=0.142; pfwe-
corr=0.825; and pfwe-corr=0.838, respectively), and are presented in Figures 23, 24 and 25.  Cluster 
M was located in the right hemisphere and included regions of the parietal, temporal, and 
occipital lobes, including the parietal superior and inferior gyri; precentral and postcentral gyri; 
supramarginal gyrus; angular gyrus, temporal superior and middle gyrus; precuneus; occipital 
middle and superior gyri. Cluster M also extended slightly to the rolandic operculum and the 
hippocampus. Cluster N was located laterally from Cluster M in the left hemisphere and included 
regions of the parietal superior and inferior gyri; postcental gyrus; precuneus, paracentral lobule, 
and superior motor area. Cluster N also extended middle cingulate cortex.  Cluster O was located 
bilaterally in the cingulate cortex and frontal lobe and included bilateral regions of the middle 
and anterior cingulate cortices; superior motor area; and frontal superior medial gyri. Cluster O 
also extended slightly to the right frontal inferior operculum and frontal superior gyrus.   
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Figure 23. Maximum voxel of significance Cluster M 
 
Figure 24. Maximum voxel of significance Cluster N 
  
 51 
 
Figure 25. Maximum voxel of significance Cluster O 
REM 
Increased relative rCMRglc during REM was associated with increased daily average nicotine 
use in two separate clusters (P and Q) of continuous voxels, with 6519 and 2339 vox els 
respectively (MNI coordinates of maximum voxel of significance: 20, -38, -32; Z = 4.62, 
puncorr=0.000; and -10, -24,56, Z = 3.84, puncorr=0.000, respectively). Clusters P and Q were 
significant without correction (puncorr=0.002; and puncorr=0.045, respectively) but not when 
corrected (pfwe-corr=0.076; and pfwe-corr=0.806, respectively), and are presented in Figures 26 and 
27.  Cluster P was located primarily in the right cerebellum and extended to the left cerebellum, 
bilateral fusiform, and brainstem.  Cluster P also extended slightly to the left parahippocampal 
gyrus; right lingual gyrus; and right temporal inferior gyrus.  S imilarly to Cluster O in 
wakefulness, Cluster Q was located primarily in the left and midline cingulate cortex and frontal 
lobes and included regions of the left and midline middle and anterior cingulate cortices; and 
superior motor area. Cluster Q also extended to the left paracentral lobule and precuneus; and 
right frontal superior gyrus.   
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Figure 26. Maximum voxel of significance Cluster P 
 
Figure 27. Maximum voxel of significance Cluster Q 
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Figure 28. Summary of whole brain analyses 
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